WO2002067239A3 - Process for preparing intermediates of hiv protease inhibitors - Google Patents
Process for preparing intermediates of hiv protease inhibitors Download PDFInfo
- Publication number
- WO2002067239A3 WO2002067239A3 PCT/US2001/051428 US0151428W WO02067239A3 WO 2002067239 A3 WO2002067239 A3 WO 2002067239A3 US 0151428 W US0151428 W US 0151428W WO 02067239 A3 WO02067239 A3 WO 02067239A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protease inhibitors
- hiv protease
- preparing intermediates
- intermediates
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01271082A EP1404680A2 (en) | 2000-10-24 | 2001-10-22 | Process for preparing intermediates of hiv protease inhibitors |
AU2002255473A AU2002255473A1 (en) | 2000-10-24 | 2001-10-22 | Process for preparing intermediates of hiv protease inhibitors |
US10/399,809 US20040026230A1 (en) | 2001-10-22 | 2001-10-22 | Process for preparing intermediates of hiv protease inhibitors |
JP2002566479A JP2004519473A (en) | 2000-10-24 | 2001-10-22 | Method for producing intermediate of HIV protease inhibitor |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24282200P | 2000-10-24 | 2000-10-24 | |
US60/242,822 | 2000-10-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002067239A2 WO2002067239A2 (en) | 2002-08-29 |
WO2002067239A3 true WO2002067239A3 (en) | 2004-01-08 |
Family
ID=22916319
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/046116 WO2002060905A2 (en) | 2000-10-24 | 2001-10-22 | Process for preparing intermediates of hiv protease inhibitors |
PCT/US2001/051428 WO2002067239A2 (en) | 2000-10-24 | 2001-10-22 | Process for preparing intermediates of hiv protease inhibitors |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/046116 WO2002060905A2 (en) | 2000-10-24 | 2001-10-22 | Process for preparing intermediates of hiv protease inhibitors |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1404680A2 (en) |
JP (1) | JP2004519473A (en) |
AU (1) | AU2002255473A1 (en) |
WO (2) | WO2002060905A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003247651A1 (en) * | 2002-06-27 | 2004-01-19 | Smithkline Beecham Corporation | PREPARATION OF STEREOISOMERS OF (3ALPHA, 3ALPHA/BETA, 6ALPHA/BETA) HEXAHYDROFURO(2,3-b)FURAN-3-OL |
ES2572001T3 (en) | 2006-03-29 | 2016-05-27 | Gilead Sciences Inc | Derived from antiviral bisfuran as an HIV protease inhibitor and intermediates thereof |
RS51675B (en) | 2006-11-09 | 2011-10-31 | Tibotec Pharmaceuticals | Methods for the preparation of hexahydrofuro[2,3-b]furan-3-ol |
CN103864813B (en) * | 2012-12-18 | 2017-02-22 | 上海迪赛诺化学制药有限公司 | Synthetic methods of hexahydrofuro[2,3-b]furan-3-ol and enantiomer thereof |
CN107607635B (en) * | 2017-08-15 | 2020-07-31 | 东北制药集团股份有限公司 | Method for detecting content of propiolic alcohol in levophosphamide salt by adopting headspace gas chromatography |
CR20220316A (en) | 2019-12-06 | 2022-10-07 | Vertex Pharma | Substituted tetrahydrofurans as modulators of sodium channels |
WO2022256622A1 (en) | 2021-06-04 | 2022-12-08 | Vertex Pharmaceuticals Incorporated | N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels |
-
2001
- 2001-10-22 EP EP01271082A patent/EP1404680A2/en not_active Withdrawn
- 2001-10-22 WO PCT/US2001/046116 patent/WO2002060905A2/en active Application Filing
- 2001-10-22 WO PCT/US2001/051428 patent/WO2002067239A2/en not_active Application Discontinuation
- 2001-10-22 AU AU2002255473A patent/AU2002255473A1/en not_active Abandoned
- 2001-10-22 JP JP2002566479A patent/JP2004519473A/en active Pending
Non-Patent Citations (4)
Title |
---|
CHIN-KANG SHA ET AL.: "Radical Cyclization of alpha-Iodo Enones by Photoinduced Electron Transfer Reaction", CHEM. COMMUN., 1998, pages 397 - 8, XP002214198 * |
COSSY J ET AL: "An Approach to the Skeleton of Eriolanin", TETRAHEDRON LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 36, no. 12, 20 March 1995 (1995-03-20), pages 2067 - 2070, XP004028406, ISSN: 0040-4039 * |
DULCÈRE, J.-P. ET AL.: "New Triethylamine induced Carbocycliation of beta-Bromopropargyl Ethers in the Pyrimidinedione Series", SYNLETT, 1995, pages 705 - 6, XP002214199 * |
JANINE COSSY ET AL.: "Formation of Radicals by Irradiation of Alkyl Halides in the Presence of Triethylamine", TETRAHEDRON LETTERS, ELEVIER SCIENCE PUBLISHERS, AMSTERDAN, NL, vol. 35, no. 44, 1994, pages 8161 - 2, XP002214197 * |
Also Published As
Publication number | Publication date |
---|---|
WO2002067239A2 (en) | 2002-08-29 |
JP2004519473A (en) | 2004-07-02 |
WO2002060905A2 (en) | 2002-08-08 |
EP1404680A2 (en) | 2004-04-07 |
AU2002255473A1 (en) | 2002-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002355718A1 (en) | Laser spectral engineering for lithographic process | |
WO2004052850A3 (en) | Methods and compounds producing dipeptidyl peptidase iv inhibitors and intermediates thereof | |
AU2003295941A1 (en) | Process for olefin production | |
HRP20040320B1 (en) | Method for the preparation of hexahydro-furo(2,3-b) furan-3-ol | |
WO2003012100A3 (en) | Method for the production of nucleic acids consisting of stochastically combined parts of source nucleic acids | |
AU2001242136A1 (en) | Amino acid derivatives as hiv aspartyl protease inhibitors | |
WO2001077360A3 (en) | Methods for ansamitocin production | |
WO2002067239A3 (en) | Process for preparing intermediates of hiv protease inhibitors | |
WO2001000577A3 (en) | Preparation of substituted piperidin-4-ones | |
AU6578400A (en) | Novel method for preparing benzoperhydroisoindole compounds | |
HK1094575A1 (en) | A process for the preparation of phenyltetrazole derivatives | |
WO2006043175A3 (en) | Process for preparing purine compounds | |
WO2003024974A3 (en) | Process for preparing protease inhibitor intermediates | |
IL156331A0 (en) | A process for the preparation of paclitaxel | |
PT1252327E (en) | PROCESS FOR THE ENZYMATIC SEPARATION OF AMINOMETHYLARIL-CYCLE-HEXANOL DERIVATIVES RACEMAT | |
AU2001250429A1 (en) | Method for producing 2-alkyl-3-chlorophenols | |
AU2002356488A1 (en) | A method of alignment by using interferometry | |
WO2004018466A3 (en) | A method of preparing enantiomers of indole-2,3-dione-3-oxime derivatives | |
DK1444244T3 (en) | Process for the preparation of desclarithromycin, as well as intermediates | |
WO2004096828A3 (en) | Novel method and intermediates for the preparation of 19-nor-steroid compounds | |
WO2003018826A3 (en) | Method for producing vitamin b12 | |
AU2002253800A1 (en) | Process for preparing intermediates of hiv protease inhibitors | |
AU2001294268A1 (en) | Process for intramolecular radical cyclization | |
AU5925498A (en) | Processes for producing 3-cyanopyridine from 2-methyl-1,5-pentanediamine | |
WO2002020490A3 (en) | Process to produce halo-4-phenoxyquinolines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
XX | Miscellaneous: |
Free format text: THE RECEIVING OFFICE HAS INFORMED THE IB THAT INTERNATIONAL APPLIC. PCT/US2001/046116 HAS BEEN ERRONEOUSLY ASSIGNED AN INTERNAT. FILING DATE AND IS VACATED AND REPLACED BY THIS INT. APPLICATION. THE NOTICE WAS RECEIVED BY THE IB IN TIME TO PREVENT THE INTERNATIONAL PUBLICATION, HOWEVER, DUE TO A CLERICAL ERROR, THE APPLICATION PCT/US2001/046116 WAS NEVERTHELESS PUBLISHED ON 20020808. |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002566479 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10399809 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001271082 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2001271082 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001271082 Country of ref document: EP |